A Study of K-645 in the Treatment of Multiple Migraine Attacks
Public ClinicalTrials.gov record NCT07116499. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled Crossover Study of K-645 in the Treatment of Multiple Migraine Attacks
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multicenter, randomized, double-blind, placebo-controlled, 3-period crossover study to evaluate the safety, tolerability, and efficacy of two dose levels of K-645 in the treatment of patients with acute migraine.
Study identification
- NCT ID
- NCT07116499
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 134 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 11, 2025
- Primary completion
- Nov 6, 2025
- Completion
- Nov 6, 2025
- Last update posted
- Nov 24, 2025
2025
United States locations
- U.S. sites
- 18
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Excell Research, Inc. | Oceanside | California | 92056 | — |
| DelRicht Research - Atlanta | Atlanta | Georgia | 30329 | — |
| Clinical Research Atlanta - Stockbridge | Stockbridge | Georgia | 30281 | — |
| Chicago Headache Center and Research Institute | Chicago | Illinois | 60657 | — |
| Collective Medical Research | Overland Park | Kansas | 66202 | — |
| L-MARC Research Center | Louisville | Kentucky | 40213 | — |
| DelRicht Research - Prairieville | Prairieville | Louisiana | 70817 | — |
| Clinical Research Institute | Minneapolis | Minnesota | 55402 | — |
| Albuquerque Clinical Trials, Inc. | Albuquerque | New Mexico | 87102 | — |
| Dent Neurosciences Research Center | Amherst | New York | 14226 | — |
| SPRI Clinical Trials, LLC | Brooklyn | New York | 11235 | — |
| Headache Wellness Center | Greensboro | North Carolina | 27405 | — |
| Peters Medical Research | High Point | North Carolina | 27260 | — |
| OK Clinical Research, LLC | Edmond | Oklahoma | 73034 | — |
| Clinical Research Associates, Inc. | Nashville | Tennessee | 37203 | — |
| DM Clinical Research - Bellaire | Houston | Texas | 77081 | — |
| APD Clinical Research | Splendora | Texas | 77372 | — |
| Health Research of Hampton Roads, Inc. | Newport News | Virginia | 23606 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07116499, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 24, 2025 · Synced Sep 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07116499 live on ClinicalTrials.gov.